In8Bio (INAB) Market Capitalization (2021 - 2026)
In8Bio's Market Capitalization came in at $27.45 million for Q2 2026, up 222.0% from $8.52 million a year earlier but down 4.7% from the prior quarter.
Analysis
In8Bio (INAB) Market Capitalization (2021 - 2026) Analysis & Trends
For FY2025, In8Bio's Market Capitalization was $10.24 million, down 25.6% from FY2024.
- Market Capitalization has declined in each of the last three years, with a four-year compound annual growth rate of -30.5% (FY2021 to FY2025).
- Going back by year, Market Capitalization was $13.76 million in FY2024 (-66.6%), $41.21 million in FY2023 (-27.3%), $56.69 million in FY2022 (+29.5%) and $43.76 million in FY2021.
- The five-year range for quarterly Market Capitalization is $8.52 million (Q2 2025) to $91.63 million (Q3 2021).
- Year-over-year, Market Capitalization increased in two of the last eight quarters, with growth averaging 1.0%.
- The fastest year-over-year change in Market Capitalization over five years came in Q2 2026 (growth of 222.0%), and the weakest in Q2 2025 (a decline of 78.3%).
- Business Quant data shows INAB's Market Capitalization at $28.81 million (Q1 2026), $10.24 million (Q4 2025) and $9.96 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn |
| 10 | In8Bio | 20.25 Mn | -58.10 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 27.45 Mn |
| Mar 31, 2026 | 28.81 Mn |
| Dec 31, 2025 | 10.24 Mn |
| Sep 30, 2025 | 9.96 Mn |
| Jun 30, 2025 | 8.52 Mn |
| Mar 31, 2025 | 13.49 Mn |
| Dec 31, 2024 | 13.76 Mn |
| Sep 30, 2024 | 12.63 Mn |
| Jun 30, 2024 | 39.33 Mn |
| Mar 31, 2024 | 52.06 Mn |
| Dec 31, 2023 | 41.21 Mn |
| Sep 30, 2023 | 33.25 Mn |
| Jun 30, 2023 | 47.13 Mn |
| Mar 31, 2023 | 32.45 Mn |
| Dec 31, 2022 | 56.69 Mn |
| Sep 30, 2022 | 49.49 Mn |
| Jun 30, 2022 | 42.57 Mn |
| Mar 31, 2022 | 62.64 Mn |
| Dec 31, 2021 | 43.76 Mn |
| Sep 30, 2021 | 91.63 Mn |
API Access
In8Bio Market Capitalization API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=market-capitalization&ticker=INAB&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "market-capitalization", "ticker": "INAB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=market-capitalization&ticker=INAB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();